LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas
L. H. Tsai, P. M. Chen, Y. W. Cheng, C. Y. Chen, G. T. Sheu, T. C. Wu, H. Lee
研究成果: 雜誌貢獻 › 文章 › 同行評審
30
引文
斯高帕斯（Scopus）